Tag: cannabis medical research

The DEA plans to reclassify cannabis from Schedule 1 to Schedule 3, acknowledging its medical benefits and opening doors for banking and research. While still federally illegal for recreational use, this change marks a significant shift towards more rational cannabis policies. Stay tuned with Ripkitty for the latest in green and dank developments.